Metropolitan Life Insurance CO Eiger Bio Pharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

  • $2.27 Billion
  • Q1 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Jun 14, 2023
BUY
$6.04 - $9.66 $14,049 - $22,469
2,326 New
2,326 $17.5 Million
Q2 2022

Jun 20, 2023
BUY
$4.99 - $8.96 $11,606 - $20,840
2,326 New
2,326 $14,000
Q1 2022

Jun 20, 2023
BUY
$3.84 - $9.74 $8,931 - $22,655
2,326 New
2,326 $19,000
Q1 2022

Mar 30, 2023
SELL
$3.84 - $9.74 $23,036 - $58,430
-5,999 Reduced 72.06%
2,326 $19,000
Q1 2022

May 12, 2022
BUY
$3.84 - $9.74 $8,931 - $22,655
2,326 New
2,326 $19,000
Q1 2021

May 14, 2021
SELL
$8.44 - $12.66 $70,263 - $105,394
-8,325 Closed
0 $0
Q4 2020

Jun 22, 2023
BUY
$7.98 - $12.29 $66,433 - $102,314
8,325 New
8,325 $102,000
Q3 2020

Jun 26, 2023
BUY
$7.96 - $12.42 $66,267 - $103,396
8,325 New
8,325 $67,000
Q2 2020

Jun 26, 2023
BUY
$5.4 - $13.37 $44,955 - $111,305
8,325 New
8,325 $79,000
Q2 2020

Mar 30, 2023
BUY
$5.4 - $13.37 $1,458 - $3,609
270 Added 3.35%
8,325 $79,000
Q2 2020

Aug 14, 2020
BUY
$5.4 - $13.37 $44,955 - $111,305
8,325 New
8,325 $80,000
Q1 2020

May 15, 2020
SELL
$4.91 - $14.7 $39,550 - $118,408
-8,055 Closed
0 $0
Q4 2019

Jul 12, 2023
BUY
$9.77 - $15.66 $78,697 - $126,141
8,055 New
8,055 $120,000
Q4 2019

Mar 30, 2023
SELL
$9.77 - $15.66 $10,590 - $16,975
-1,084 Reduced 11.86%
8,055 $120,000
Q4 2019

Feb 14, 2020
SELL
$9.77 - $15.66 $10,590 - $16,975
-1,084 Reduced 11.86%
8,055 $120,000
Q3 2019

Jul 12, 2023
BUY
$9.59 - $12.0 $87,643 - $109,668
9,139 New
9,139 $93,000
Q3 2019

Mar 30, 2023
BUY
$9.59 - $12.0 $87,643 - $109,668
9,139 New
9,139 $93,000
Q3 2019

Nov 14, 2019
BUY
$9.59 - $12.0 $87,643 - $109,668
9,139 New
9,139 $94,000
Q2 2019

Jul 12, 2023
BUY
$9.54 - $14.96 $19,013 - $29,815
1,993 New
1,993 $21.1 Million

Others Institutions Holding EIGR

# of Institutions
6
Shares Held
748K
Call Options Held
0
Put Options Held
0
View Full List

About Eiger BioPharmaceuticals, Inc.

EIGR Quotes by TradingView
  • Ticker EIGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,966,800
  • Market Cap $496M
  • Description
  • Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...
More about EIGR
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email